U of T receives $3M to establish endowed AbbVie Chair of Ethnodermatology

The University of Toronto’s Temerty Faculty of Medicine will be establishing the AbbVie Chair in Ethnodermatology through a $3M donation from biopharmaceutical company AbbVie. The endowed chair will focus on driving collaborative academic research, training dermatological practitioners, and leading outreach programs. The chair will also aim to address inequalities and gaps in dermatological research, education, and patient care that create inequities for patients of colour. “In a field that focuses on skin, dermatology has a particular responsibility to identify and address racial inequities that influence health outcomes,” said Temerty Medicine Acting Dean and Vice-Dean Dr Patricia Houston. “The creation of the AbbVie Chair in Ethnodermatology represents a milestone philanthropic investment in our Faculty’s ongoing efforts to advance health equity.” U of T Note: Archived stories may contain dead links or be missing source links.

U of T | U of T | U of T